Express Scripts, CVS Face ERISA Suit Over EpiPen Costs

By Dani Kass · June 5, 2017, 6:16 PM EDT

Express Scripts, CVS Health and Prime Therapeutics on Friday were drawn into the conflict over how EpiPens became so expensive after a potential class of patients accused the pharmacy benefit managers...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

In re EpiPen ERISA Litigation (Klein et al v. Prime Therapeutics, LLC et al)

Case Number

Court

Minnesota

Nature of Suit

Labor: E.R.I.S.A.

Date Filed

June 02, 2017

Recent Articles By Dani

May 13, 2025
Split PTAB Cites SAS To Reject Samsung Petition
May 01, 2025
US Tells Justices Telemedicine Case Isn't Ideal For Eligibility
March 12, 2025
Law360 Cheat Sheet: Novartis' Fight Over Generic Entresto
March 05, 2025
Pfizer, BioNTech Get PTAB To Invalidate Moderna Vaccine IP
February 24, 2025
Fed. Circ. Shouldn't Assume Doctors Read Labels, Profs Say
January 28, 2025
GSK Urges Del. Judge To Enhance $235M Skinny Label Win
January 13, 2025
Supreme Court Turns Away IP Safe Harbor Dispute
January 01, 2025
Patent Cases To Watch In 2025
December 20, 2024
Sens. Aim To Protect Generics With Skinny Labels In New Bill
December 18, 2024
Patent Limits For Biosimilar Litigation Lands In Spending Bill